Drug intelligence / Profile preview

hydroxytyrosol

Development stage
Phase 3
Lead developer
Creagri
Modality
Small Molecules
Administration
Oral
01

Overview

Hydroxytyrosol is a naturally occurring phenolic phytochemical found primarily in olives and extra virgin olive oil. It is recognized for its potent antioxidant and anti-inflammatory properties, as well as potential anticancer and cardioprotective effects[1][2][4]. Mechanistically, hydroxytyrosol acts by scavenging reactive oxygen species (ROS), regulating the intracellular redox state, inhibiting cyclooxygenase (COX) and lipoxygenase (LOX) enzymes involved in inflammation, and modulating key cellular pathways such as AMPK/FOXO3a and PI3K/AKT/mTOR[2][6]. These actions contribute to its ability to protect low-density lipoproteins from oxidation—an effect highlighted by the European Food Safety Authority for cardiovascular risk reduction[4]. Hydroxytyrosol has been investigated in clinical trials for disease prevention, including breast cancer[3], but is primarily used as a dietary supplement or nutraceutical ingredient rather than a pharmaceutical drug.

Brand names
Olixia PureHytolive
Other names
2-(3,4-dihydroxyphenyl)ethanolHXT
02

Targets

15-LOX (Lysyl Oxidase)COX

Beyond the preview

Go deeper on hydroxytyrosol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hydroxytyrosol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call